Skip to Content

Aethlon Medical Inc AEMD Stock Quote

| Rating as of

NASDAQ:AEMD

Morningstar‘s Stock Analysis AEMD

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics AEMD

Company Profile AEMD

Business Description

Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense. The company operates through two segments namely Aethlon for therapeutic applications, which represents its therapeutic business activities and ESI for diagnostic applications which signifies diagnostic business activities. It is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and to eliminate life-threatening viruses from the circulatory system. The company generates revenue from Aethlon segment.

Contact
11555 Sorrento Valley Road, Suite 203
San Diego, CA, 92121
T +1 619 941-0360
Industry Medical Devices
Most Recent Earnings Sep 30, 2022
Fiscal Year End Mar 31, 2023
Employees 14